Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

COTI-2 (CAS 1039455-84-9)

0.0(0)
Write a reviewAsk a question

Datasheets
CAS Number:
1039455-84-9
Molecular Weight:
366.48
Molecular Formula:
C19H22N6S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

QUICK LINKS


COTI-2 (CAS 1039455-84-9) References

  1. Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.  |  Maleki Vareki, S., et al. 2018. PLoS One. 13: e0191766. PMID: 29364966
  2. Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic Strategies.  |  Kaur, RP., et al. 2018. Curr Pharm Des. 24: 3566-3575. PMID: 30255744
  3. COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.  |  Lindemann, A., et al. 2019. Clin Cancer Res. 25: 5650-5662. PMID: 31308060
  4. COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells.  |  Synnott, NC., et al. 2020. Breast Cancer Res Treat. 179: 47-56. PMID: 31538264
  5. COTI-2 induces cell apoptosis in pediatric acute lymphoblastic leukemia via upregulation of miR-203.  |  Guo, Y., et al. 2020. Bioengineered. 11: 201-208. PMID: 32063077
  6. Liposomal formulations of anticancer copper(II) thiosemicarbazone complexes.  |  Mathuber, M., et al. 2021. Dalton Trans. 50: 16053-16066. PMID: 34617075
  7. Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.  |  de Bakker, T., et al. 2021. Front Oncol. 11: 799993. PMID: 35071005
  8. Gain of Function (GOF) Mutant p53 in Cancer-Current Therapeutic Approaches.  |  Roszkowska, KA., et al. 2022. Int J Mol Sci. 23: PMID: 36362074
  9. Therapeutic Targeting of P53: A Comparative Analysis of APR-246 and COTI-2 in Human Tumor Primary Culture 3-D Explants.  |  Nagourney, AJ., et al. 2023. Genes (Basel). 14: PMID: 36981018
  10. Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells.  |  Tang, M., et al. 2023. Invest New Drugs. 41: 541-550. PMID: 37233863

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

COTI-2, 25 mg

sc-507291
25 mg
$310.00